Patients with SLE exhibit reduced IgM/IgG anti-phosphocholine (PC) levels inversely associated with AS severity (81–85), where IgM anti-PC mitigates disease activity while IgG anti-PC inhibits endothelial adhesion molecules (83–85). Here, CD40LG is linked to systemic lupus erythematosus.